956 related articles for article (PubMed ID: 22901803)
21. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
22. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization.
Lv L; Xu YP; Zhao D; Li FL; Wang W; Sasaki N; Jiang Y; Zhou X; Li TT; Guan KL; Lei QY; Xiong Y
Mol Cell; 2013 Nov; 52(3):340-52. PubMed ID: 24120661
[TBL] [Abstract][Full Text] [Related]
23. TSP50 promotes the Warburg effect and hepatocyte proliferation via regulating PKM2 acetylation.
Gao F; Zhang X; Wang S; Zheng L; Sun Y; Wang G; Song Z; Bao Y
Cell Death Dis; 2021 May; 12(6):517. PubMed ID: 34016961
[TBL] [Abstract][Full Text] [Related]
24. Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells.
Wang LY; Liu YP; Chen LG; Chen YL; Tan L; Liu JJ; Jazag A; Ren JL; Guleng B
PLoS One; 2013; 8(6):e67542. PubMed ID: 23840737
[TBL] [Abstract][Full Text] [Related]
25. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
26. G9a inhibition induced PKM2 regulates autophagic responses.
Ahmad F; Dixit D; Joshi SD; Sen E
Int J Biochem Cell Biol; 2016 Sep; 78():87-95. PubMed ID: 27417236
[TBL] [Abstract][Full Text] [Related]
27. Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor.
Matsuda S; Adachi J; Ihara M; Tanuma N; Shima H; Kakizuka A; Ikura M; Ikura T; Matsuda T
Nucleic Acids Res; 2016 Jan; 44(2):636-47. PubMed ID: 26405201
[TBL] [Abstract][Full Text] [Related]
28. Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis.
Lu Z
Chin J Cancer; 2012 Jan; 31(1):5-7. PubMed ID: 22200182
[TBL] [Abstract][Full Text] [Related]
29. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [
Patel CB; Beinat C; Xie Y; Chang E; Gambhir SS
Neoplasia; 2021 Jan; 23(1):58-67. PubMed ID: 33221711
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract][Full Text] [Related]
31. Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells.
de Wit RH; Mujić-Delić A; van Senten JR; Fraile-Ramos A; Siderius M; Smit MJ
Oncotarget; 2016 Oct; 7(42):67966-67985. PubMed ID: 27602585
[TBL] [Abstract][Full Text] [Related]
32. KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer.
Zhang C; Huang Z
Mol Biotechnol; 2024 Jun; 66(6):1446-1457. PubMed ID: 37294531
[TBL] [Abstract][Full Text] [Related]
33. Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms.
Liu J; Wu N; Ma L; Liu M; Liu G; Zhang Y; Lin X
PLoS One; 2014; 9(3):e91606. PubMed ID: 24626155
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
35. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J
Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489
[TBL] [Abstract][Full Text] [Related]
36. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells.
Keller KE; Doctor ZM; Dwyer ZW; Lee YS
Mol Cell; 2014 Mar; 53(5):700-9. PubMed ID: 24606918
[TBL] [Abstract][Full Text] [Related]
37. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
Liu X; Zhu Q; Guo Y; Xiao Z; Hu L; Xu Q
Biomed Pharmacother; 2019 Sep; 117():109069. PubMed ID: 31181442
[TBL] [Abstract][Full Text] [Related]
38. Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis.
Zheng D; Jiang Y; Qu C; Yuan H; Hu K; He L; Chen P; Li J; Tu M; Lin L; Chen H; Lin Z; Lin W; Fan J; Cheng G; Hong J
Am J Pathol; 2020 Nov; 190(11):2267-2281. PubMed ID: 32805235
[TBL] [Abstract][Full Text] [Related]
39. AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth.
Park YS; Kim DJ; Koo H; Jang SH; You YM; Cho JH; Yang SJ; Yu ES; Jung Y; Lee DC; Kim JA; Park ZY; Park KC; Yeom YI
Oncotarget; 2016 Jul; 7(30):48155-48167. PubMed ID: 27340866
[TBL] [Abstract][Full Text] [Related]
40. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.
Zheng S; Liu Q; Liu T; Lu X
J Physiol Biochem; 2021 Aug; 77(3):355-363. PubMed ID: 33835423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
